169 related articles for article (PubMed ID: 37815060)
1. Effect of Peripheral Blood Lymphocytes on Prognosis of Multiple Cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.
Murta EF; de Andrade JM; Falcão RP; Bighetti S
Tumori; 2000; 86(5):403-7. PubMed ID: 11130570
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
4. The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.
Dai S; Ren P; Ren J; Yang L; Li W
Int J Med Sci; 2021; 18(10):2228-2234. PubMed ID: 33859531
[No Abstract] [Full Text] [Related]
5. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.
Liu S; Lachapelle J; Leung S; Gao D; Foulkes WD; Nielsen TO
Breast Cancer Res; 2012 Mar; 14(2):R48. PubMed ID: 22420471
[TBL] [Abstract][Full Text] [Related]
6. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
7. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
[TBL] [Abstract][Full Text] [Related]
8. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy.
Zhang GQ; Zhao H; Wu JY; Li JY; Yan X; Wang G; Wu LL; Zhang XG; Shao Y; Wang Y; Jiao SC
World J Gastroenterol; 2015 Mar; 21(9):2777-85. PubMed ID: 25759549
[TBL] [Abstract][Full Text] [Related]
9. The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients.
Liu A; Xia Y; Li W; Zhang G; Liu Y; Ye S; Zhao ZR; Yang Y; Jia Y; Guo Y; Liu X; Chen H; Yu J
Contrast Media Mol Imaging; 2022; 2022():3444360. PubMed ID: 36051923
[TBL] [Abstract][Full Text] [Related]
10. Discovery and characteristics of B cell-like T cells: A potential novel tumor immune marker?
Liu Y; Ye S; Guo X; Li W; Xia Y; Wen X; Yu J; Jia Y; Liu X; Guo Y; Zhao Y
Immunol Lett; 2020 Apr; 220():44-50. PubMed ID: 32014490
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients.
Wu Y; Ye S; Goswami S; Pei X; Xiang L; Zhang X; Yang H
BMC Cancer; 2020 Mar; 20(1):173. PubMed ID: 32131750
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy.
Chen L; Hao Y; Cong X; Zou M; Li S; Zhu L; Song H; Xue Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819829485. PubMed ID: 30760114
[TBL] [Abstract][Full Text] [Related]
13. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Li M; Xu J; Jiang C; Zhang J; Sun T
Front Oncol; 2022; 12():842705. PubMed ID: 35242718
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
15. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
16. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
18. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
19. A low proportion of regulatory T cells before chemoradiotherapy predicts better overall survival in esophageal cancer.
Lan F; Xu B; Li J
Ann Palliat Med; 2021 Feb; 10(2):2195-2202. PubMed ID: 33725774
[TBL] [Abstract][Full Text] [Related]
20. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.
Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C
Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
